1. Home
  2. CRL vs BTG Comparison

CRL vs BTG Comparison

Compare CRL & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • BTG
  • Stock Information
  • Founded
  • CRL 1947
  • BTG 2006
  • Country
  • CRL United States
  • BTG Canada
  • Employees
  • CRL N/A
  • BTG N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • BTG Precious Metals
  • Sector
  • CRL Health Care
  • BTG Basic Materials
  • Exchange
  • CRL Nasdaq
  • BTG Nasdaq
  • Market Cap
  • CRL 7.3B
  • BTG 7.5B
  • IPO Year
  • CRL 2000
  • BTG N/A
  • Fundamental
  • Price
  • CRL $168.10
  • BTG $3.81
  • Analyst Decision
  • CRL Buy
  • BTG Buy
  • Analyst Count
  • CRL 16
  • BTG 2
  • Target Price
  • CRL $190.86
  • BTG $6.25
  • AVG Volume (30 Days)
  • CRL 1.1M
  • BTG 54.0M
  • Earning Date
  • CRL 11-05-2025
  • BTG 11-05-2025
  • Dividend Yield
  • CRL N/A
  • BTG 2.48%
  • EPS Growth
  • CRL N/A
  • BTG N/A
  • EPS
  • CRL N/A
  • BTG N/A
  • Revenue
  • CRL $4,023,704,000.00
  • BTG $2,172,330,000.00
  • Revenue This Year
  • CRL N/A
  • BTG $70.19
  • Revenue Next Year
  • CRL $2.43
  • BTG $16.40
  • P/E Ratio
  • CRL N/A
  • BTG N/A
  • Revenue Growth
  • CRL N/A
  • BTG 11.75
  • 52 Week Low
  • CRL $91.86
  • BTG $2.20
  • 52 Week High
  • CRL $230.02
  • BTG $5.94
  • Technical
  • Relative Strength Index (RSI)
  • CRL 41.64
  • BTG 28.03
  • Support Level
  • CRL $160.01
  • BTG $3.98
  • Resistance Level
  • CRL $180.19
  • BTG $5.07
  • Average True Range (ATR)
  • CRL 6.82
  • BTG 0.25
  • MACD
  • CRL -2.82
  • BTG -0.18
  • Stochastic Oscillator
  • CRL 20.40
  • BTG 4.21

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

Share on Social Networks: